Market Cap 1.53B
Revenue (ttm) 1.11B
Net Income (ttm) 12.53M
EPS (ttm) N/A
PE Ratio 30.80
Forward PE 41.96
Profit Margin 1.13%
Debt to Equity Ratio 0.00
Volume 375,200
Avg Vol 441,290
Day's Range N/A - N/A
Shares Out 45.93M
Stochastic %K 96%
Beta 0.95
Analysts Strong Sell
Price Target $46.40

Company Profile

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care...

Industry: Health Information Services
Sector: Healthcare
Phone: 877 415 9990
Address:
4220 North Freeway, Suite 301, Fort Worth, United States
ZacksResearch
ZacksResearch Nov. 4 at 4:00 PM
Robotics stocks are heating up for 2025 🔥 $PATH, $EMR, $TRMB, $OMCL and $LECO are all leveraging extensive robotics applications — positioning them for solid momentum into year-end. Find out which of these names could lead the next robotics rally 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-teaser-19281&ADID=SYND_STOCKTWITS_TWEET_2_2784478_TEASER_19281
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 3:00 PM
Why invest in robotics stocks now? 🤖🚀 Major players like $PATH, $EMR, $TRMB, $OMCL, and $LECO are poised for growth with a mix of Zacks Ranks #1 and #2 and impressive earnings outlooks. With advancements in AI and automation, these stocks could see significant returns. Discover the full list of top picks here 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-body-19280&ADID=SYND_STOCKTWITS_TWEET_2_2784478_BODY_19280
0 · Reply
SeanDavid
SeanDavid Oct. 31 at 5:37 PM
$AMZN showed retail efficiency, ads strength, and steady AWS growth. +20% looks like for calendar Q4. Bedrock and Q are pulling workloads from testing to production, creating recurring compute demand rather than GPU one-offs. CAPEX $Z Zillow signaled 2026 growth like 2025, in the teens for revenue. Also expects 2% margin expansion which signals 20% or more earnings power. They only assume flat housing activity. Rentals 40% growth and they expect 45% next Q, which means $1B on track. $OMCL Omnicell expanding its recurring base and cloud becoming part of the software story. Big wins in Q and founder Randall seemed very optimistic. $MCW Mister Car Wash sounded very constructive. Ability to build or buy now. Signals unit growth above street’s 30 annually. Acquired 5 in Lubbock. Margins intact and multiples on acquisitions attractive. Growth story intact and cheap.
0 · Reply
MaverikIT
MaverikIT Oct. 30 at 2:55 PM
$OMCL +3.22 nice ER Omnicell Reports Bullish Q3, Stock Soars
0 · Reply
DonCorleone77
DonCorleone77 Oct. 30 at 10:58 AM
$OMCL Omnicell reports Q3 non-GAAP EPS 51c, consensus 36c -- Q3 revenue $311M, consensus $295.59M. -- Sees Q4 non-GAAP EPS 40c-50c, consensus 48c. -- Sees Q4 revenue $306M-$3169M, consensus $295.32M.
0 · Reply
AlexSwiss77
AlexSwiss77 Oct. 30 at 10:44 AM
$OMCL best on Revenue /EPS !!
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 12:35 PM
$OMCL — Can SaaS & Expert Services Fuel a Comeback? 🚀 Despite losing 29.1% over the past year, Omnicell's SaaS and Expert Services could help sustain growth with market demand and geographic expansion plans. Plus, a robust solvency position adds stability. Discover more about OMCL’s growth strategy here 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-body-14846&ADID=SYND_STOCKTWITS_TWEET_2_2763380_BODY_14846
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 11:35 AM
$OMCL — Hidden growth story in healthcare tech? 👀 Expanding SaaS offerings, global expansion plans, and a strong balance sheet are fueling real momentum — even with rising competition in the mix. Discover why OMCL could be a smart addition right now 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-teaser-14845&ADID=SYND_STOCKTWITS_TWEET_2_2763380_TEASER_14845
0 · Reply
OrtexOracle
OrtexOracle Oct. 5 at 3:36 PM
$OMCL Healthcare technology growth. Testing resistance level. Volume expansion needed for continuation. Sector momentum.
0 · Reply
AlexSwiss77
AlexSwiss77 Sep. 24 at 9:28 PM
$OMCL adding in low 30s
0 · Reply
Latest News on OMCL
Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 3:36 PM EDT - 5 days ago

Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript


Omnicell Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 6:30 AM EDT - 5 days ago

Omnicell Announces Third Quarter 2025 Financial Results


Omnicell Q2 Earnings: Market Ignoring The Segments

Jul 31, 2025, 11:45 AM EDT - 3 months ago

Omnicell Q2 Earnings: Market Ignoring The Segments


Omnicell Announces Second Quarter 2025 Results

Jul 31, 2025, 6:30 AM EDT - 3 months ago

Omnicell Announces Second Quarter 2025 Results


Omnicell Opens New Innovation Lab in Austin, Texas

May 14, 2025, 8:30 AM EDT - 6 months ago

Omnicell Opens New Innovation Lab in Austin, Texas


Omnicell: Facing New Headwinds

May 7, 2025, 1:25 PM EDT - 6 months ago

Omnicell: Facing New Headwinds


Omnicell Announces First Quarter 2025 Results

May 6, 2025, 6:30 AM EDT - 6 months ago

Omnicell Announces First Quarter 2025 Results


Omnicell Announces Chief Financial Officer Transition

Mar 12, 2025, 8:30 AM EDT - 8 months ago

Omnicell Announces Chief Financial Officer Transition


Omnicell Q4 Earnings: Ignore The Short-Term Noise

Feb 12, 2025, 7:44 AM EST - 9 months ago

Omnicell Q4 Earnings: Ignore The Short-Term Noise


Omnicell, Inc. (OMCL) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 1:24 PM EST - 9 months ago

Omnicell, Inc. (OMCL) Q4 2024 Earnings Call Transcript


Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

Feb 6, 2025, 6:30 AM EST - 9 months ago

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results


Omnicell Announces OmniSphere

Dec 9, 2024, 8:30 AM EST - 11 months ago

Omnicell Announces OmniSphere


Omnicell Q3 Earnings: Look At The Growth Segment

Nov 1, 2024, 11:58 AM EDT - 1 year ago

Omnicell Q3 Earnings: Look At The Growth Segment


Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 2:07 PM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript


Omnicell Announces Third Quarter 2024 Results

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Third Quarter 2024 Results


Omnicell Announces Central Med Automation Service

Aug 20, 2024, 4:30 PM EDT - 1 year ago

Omnicell Announces Central Med Automation Service


Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript

Aug 4, 2024, 1:49 AM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript


Omnicell Announces Second Quarter 2024 Results

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Second Quarter 2024 Results


Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript

May 2, 2024, 2:22 PM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript


Omnicell Announces First Quarter 2024 Results

May 2, 2024, 7:30 AM EDT - 1 year ago

Omnicell Announces First Quarter 2024 Results


Omnicell Announces XT Amplify

Apr 16, 2024, 4:01 PM EDT - 1 year ago

Omnicell Announces XT Amplify


Omnicell Is Building A Strong Moat

Feb 22, 2024, 6:20 AM EST - 1 year ago

Omnicell Is Building A Strong Moat


Omnicell, Inc. (OMCL) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 6:03 PM EST - 1 year ago

Omnicell, Inc. (OMCL) Q4 2023 Earnings Call Transcript


Omnicell Elects Eileen Voynick to Board of Directors

Jan 11, 2024, 4:00 PM EST - 1 year ago

Omnicell Elects Eileen Voynick to Board of Directors


Omnicell, Inc. (OMCL) Q3 2023 Earnings Call Transcript

Nov 5, 2023, 1:51 AM EDT - 2 years ago

Omnicell, Inc. (OMCL) Q3 2023 Earnings Call Transcript


ZacksResearch
ZacksResearch Nov. 4 at 4:00 PM
Robotics stocks are heating up for 2025 🔥 $PATH, $EMR, $TRMB, $OMCL and $LECO are all leveraging extensive robotics applications — positioning them for solid momentum into year-end. Find out which of these names could lead the next robotics rally 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-teaser-19281&ADID=SYND_STOCKTWITS_TWEET_2_2784478_TEASER_19281
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 3:00 PM
Why invest in robotics stocks now? 🤖🚀 Major players like $PATH, $EMR, $TRMB, $OMCL, and $LECO are poised for growth with a mix of Zacks Ranks #1 and #2 and impressive earnings outlooks. With advancements in AI and automation, these stocks could see significant returns. Discover the full list of top picks here 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-body-19280&ADID=SYND_STOCKTWITS_TWEET_2_2784478_BODY_19280
0 · Reply
SeanDavid
SeanDavid Oct. 31 at 5:37 PM
$AMZN showed retail efficiency, ads strength, and steady AWS growth. +20% looks like for calendar Q4. Bedrock and Q are pulling workloads from testing to production, creating recurring compute demand rather than GPU one-offs. CAPEX $Z Zillow signaled 2026 growth like 2025, in the teens for revenue. Also expects 2% margin expansion which signals 20% or more earnings power. They only assume flat housing activity. Rentals 40% growth and they expect 45% next Q, which means $1B on track. $OMCL Omnicell expanding its recurring base and cloud becoming part of the software story. Big wins in Q and founder Randall seemed very optimistic. $MCW Mister Car Wash sounded very constructive. Ability to build or buy now. Signals unit growth above street’s 30 annually. Acquired 5 in Lubbock. Margins intact and multiples on acquisitions attractive. Growth story intact and cheap.
0 · Reply
MaverikIT
MaverikIT Oct. 30 at 2:55 PM
$OMCL +3.22 nice ER Omnicell Reports Bullish Q3, Stock Soars
0 · Reply
DonCorleone77
DonCorleone77 Oct. 30 at 10:58 AM
$OMCL Omnicell reports Q3 non-GAAP EPS 51c, consensus 36c -- Q3 revenue $311M, consensus $295.59M. -- Sees Q4 non-GAAP EPS 40c-50c, consensus 48c. -- Sees Q4 revenue $306M-$3169M, consensus $295.32M.
0 · Reply
AlexSwiss77
AlexSwiss77 Oct. 30 at 10:44 AM
$OMCL best on Revenue /EPS !!
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 12:35 PM
$OMCL — Can SaaS & Expert Services Fuel a Comeback? 🚀 Despite losing 29.1% over the past year, Omnicell's SaaS and Expert Services could help sustain growth with market demand and geographic expansion plans. Plus, a robust solvency position adds stability. Discover more about OMCL’s growth strategy here 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-body-14846&ADID=SYND_STOCKTWITS_TWEET_2_2763380_BODY_14846
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 11:35 AM
$OMCL — Hidden growth story in healthcare tech? 👀 Expanding SaaS offerings, global expansion plans, and a strong balance sheet are fueling real momentum — even with rising competition in the mix. Discover why OMCL could be a smart addition right now 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-teaser-14845&ADID=SYND_STOCKTWITS_TWEET_2_2763380_TEASER_14845
0 · Reply
OrtexOracle
OrtexOracle Oct. 5 at 3:36 PM
$OMCL Healthcare technology growth. Testing resistance level. Volume expansion needed for continuation. Sector momentum.
0 · Reply
AlexSwiss77
AlexSwiss77 Sep. 24 at 9:28 PM
$OMCL adding in low 30s
0 · Reply
Eroc
Eroc Aug. 25 at 3:53 PM
$OMCL longer term swing on this one. Looking for $50+
0 · Reply
AlexSwiss77
AlexSwiss77 Aug. 22 at 7:38 PM
$OMCL holding half and selling half
0 · Reply
Eroc
Eroc Aug. 22 at 2:12 PM
$OMCL looking strong! may finally be breaking out of range. Need her to close up above $32.40 today. Start widening the gap away from the 20MA and back above the 200MA.
0 · Reply
Eroc
Eroc Aug. 15 at 1:46 PM
$OMCL after yesteerday's action with its v bottom intraday, if we can hold these levels or higher thru close today, $35+ will be our next stop. Let's go bulls!
0 · Reply
Eroc
Eroc Aug. 13 at 7:26 PM
$OMCL love the v bottom recover today! Looking for a 25%+ gainer from current levels! Let's go bulls!
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 1:01 PM
Piper Sandler updates rating for Omnicell ( $OMCL ) to Overweight, target set at 57 → 55.
0 · Reply
wickray
wickray Aug. 7 at 6:57 AM
$OMCL Healthcare software testing $30 resistance. Recent golden cross adds confirmation. Needs volume breakout.
0 · Reply
Pinotwinelover
Pinotwinelover Aug. 1 at 1:22 AM
$OMCL average share price 27. 49 cost averaging bought a lot luckily at a low point think this popped up to about 34 but I forgot I had a trailing stop loss and once it dropped 5.2% from the high, I got rid of it all I’ll watch and see if I should get back in
0 · Reply
Yassaom
Yassaom Jul. 31 at 2:25 PM
$OMCL whats happened???
0 · Reply
AlexSwiss77
AlexSwiss77 Jul. 31 at 1:28 PM
$OMCL excellent day and earning surprise holding strong to 40s !!
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 31 at 12:12 PM
$OMCL (+11.5% pre) Omnicell: Q2 Earnings Snapshot https://ooc.bz/l/72077
0 · Reply
DonCorleone77
DonCorleone77 Jul. 31 at 10:59 AM
$OMCL Omnicell reports Q2 non-GAAP EPS 45c, consensus 27c -- Q2 revenue $291M, consensus $275.24M. -- Sees Q3 non-GAAP EPS 30c-37c, consensus 37c -- Sees Q3 revenue $290M-$300M, consensus $284.1M. -- Lowers 2025 non-GAAP EPS view to $1.40-$1.65 from $1.65-$1.85, Consensus $1.37. -- Raises 2025 revenue view to $1.13B-$1.16B from $1.105B-$1.155B, consensus $1.13B.
0 · Reply